Objective: Sternum infection remains one of the primary causes of postoperative morbidity and mortality after median sternotomy. We report the clinical efficacy for primary reinforcement of the sternum with a new design of thorax support vest. Methods: A prospective randomized study including 455 patients was started in September 2007 to evaluate the effectiveness of the Posthorax W sternum vest (Epple Inc., Vienna, Austria). One hundred and seventy five patients were treated with the sternum dressing postoperatively (group A), 227 patients did not receive the vest (group B) and 53 patients refused it (group C). Several clinical and operative data were evaluated. All patients were recorded using the STS risk scoring analysis for mediastinitis after cardiac surgery. Results: The median age and gender distribution were comparable in both groups. Preoperative data like renal failure, chronic obstructive pulmonary disease, peripheral artery disease, and myocardial infarction were not significant. There were more patients with diabetes in group A and C (A: 39.4%, B: 29.1%, C: 43.4%, p = 0.036). A total of 55.8% underwent coronary bypass grafting, 15.4% aortic valve replacement, 7.7% mitral valve repair and 21.1% concomitant cardiac procedures. The median risk factor analysis and body mass index were comparable. In the follow-up period up to 90 days, in group A we observed 0.6% sternum wound complications, in group B 4.9%, and in group C 9.4% (group A vs B: Fisher's exact test p = 0.0152 and group A vs C: p = 0.0029). Conclusions: The use of the Posthorax W sternum vest shows a favourable outcome to prevent sternum instability after cardiac surgery. There was one reoperation in patients treated with this sternum vest compared to 16 in the control groups. #
Introduction
Sternal instability caused by dehiscence or infection is still a serious complication after cardiac surgery. Sternal wound dehiscence occurs in up to 10% [1, 2] , and infections in 1-4% after sternotomy [3] [4] [5] . Their consequences are severe with an in hospital mortality up to 25% [6, 7] , high morbidity, prolonged hospital stay and additional cost estimated to be 2.8 times [4] higher compared to uncomplicated postoperative course.
Several risk factors and causes associated with sternal complications have been examined in studies [8] [9] [10] [11] [12] [13] [14] [15] presenting obesity, age, diabetes, chronic obstructive pulmonary disease (COPD), use of bilateral mammary arteries, duration of surgery, prolonged mechanical ventilation and re-exploration for bleeding as related factors for the development of sternum infections.
Sternum wound problems (complications) become clinically apparent between 4 and 90 days postoperatively [16] , remarkably, 49% of sternal wound infections were diagnosed post-discharge [17] .
This study was established to evaluate the clinical efficacy for primary reinforcement of the sternum with the Posthorax W vest (Epple Inc., Vienna, Austria) in prospective, randomised controlled study.
Materials and methods
Four hundred and fifty five patients were included in this study conducted in our department since September 2007. The work was approved by the local ethics committee, each patient providing informed consent. Patients were randomised immediately after operation, the sternum vest was put on within 24 All patients were stratified using a modified STS risk score analysis for major infection after cardiac surgery [18] , demonstrated in Table 1 ; postoperatively the pain score was evaluated daily using the visual analog scale [19] . Exclusion criteria were age under 20 years, congenital cardiac defect, mechanical reanimation, and irradiation of the thorax. Patients who refused the sternum vest were analysed in a separate group (n = 53). Patients who refused the sternum support were complaining about the close fit and slipping of the vest.
Patients were followed for the prevalence of sternal dehiscence or wound infection for 90 days after cardiac surgery. Sternal wound infections included superficial infections, involving skin and subcutaneous tissue of the incision, and deep infections. Infection data were collected during hospitalisation using medical records. After discharge patients were monitored by visiting the outpatient clinic or by telephone questionnaire concerning sternal wound problems during the 90-day follow-up period.
Design of the thorax support vest
The Posthorax W sternum vest (Epple Inc., Vienna, Austria) provides anteroposterior stabilisation of the thorax. Two pads placed on each side of the sternum, ergonomically fitted for males and females, prevent intrinsic movement of the two sternum halves (Fig. 1 ). Lateral flaps are designed for optimum fit, allow for normal breathing and stop over-extension. The individual sizing and upper straps stop the thorax support vest sliding to the abdominal region.
Statistical methods
Statistical analysis was performed using Software StatXact W -8 with Cytel Studio TM (Cytel Inc., Cambridge, MA) and Statistica V 8.0 Statsoft W (StatSoft Inc., Tulsa, OK). Differences between the patient groups, with respect to sample size were analysed using Fisher-Freeman-Halton test comparing all groups and Fisher's exact test calculating differences between particular groups. The alpha value was lowered with Bonferroni correction to avoid spurious positive significance levels (alpha/3 = 0.0167). Kruskal-Wallis ANOVA test was used to determine mean values including standard deviation as shown in Table 2 . The Mann-Whitney U test was used to assess the distribution between length of hospital stay and ventilation time between patients with or without sternal wound complications. p Values of <0.05 were considered to indicate significance.
Results
Patient characteristics including risk factors such as diabetes, chronic renal failure, peripheral artery disease, chronic obstructive pulmonary disease, acute myocardial infarction (<21 days), and cardiogenic shock are summarised in Table 2 . The two randomised groups (vest [group A] and non-vest group [group B]) were well matched on demographic and comorbidity features with the exception of diabetes, which was more prevalent in patients who received (39.4%) and who refused (43.4%) the support vest [group C] ( p = 0.036). The mean age was 68.6 (AE10.5 SD, range 34-87) years, 79% male in the non-vest, 73.1% in the vest group, and 71.7% in the group who refused the vest.
The New York Heart Association (NYHA) classification was median 3 in all groups, the body mass index (A: median 27.2 vs B: 27.6 vs C: 26.9), infection risk score (A: 9 AE 4.6 vs B: Operative and perioperative details shown in Table 3 reached no statistical significance including ventilation hours, concomitant surgery (e.g. valve and coronary artery bypass grafting), and length of hospital stay. In group C there were more patients with perfusion time between 200 and 300 min (A: 2.9%; B: 2.2%; C: 9.4%; p = 0.045).
Of the 227 patients without sternum vest, sternal wound complications developed in 11 (4.9%). Deep sternal infections occurred in seven patients (three, 1%), sternum dehiscence in one (0.4%), and superficial sternal wound complications in three (1.3%). Of the 175 randomised patients with the sternum support vest only one superficial sternum complication was detected (0.6%). Of the 53 patients who refused the vest 5 developed complications (9.4%) including 4 deep sternal infections (7.5%) and 1 superficial wound problem (1.9%). All complications needed surgical revision and were treated by surgical debridement, VAC-system implantation, and, if necessary, recerclage.
These findings show highly significant differences in sternal complications between the groups (Fisher-Freeman-Halton test p = 0.0026). After Bonferroni correction (alpha/3 = 0.0167) there is still a significant difference between the vest group and the non-vest or refused vest group (group A vs B: Fisher's exact test p = 0.0152 and group A vs C: p = 0.0029). In the analysis comparing the non-vest group with the group refusing the vest there was no statistical difference (Fisher's exact test p = 0.1961). Interestingly, four (25%) patients developed sternal wound complications after hospital discharge up to 90 days. Variables were expressed as number (%), or mean AE standard deviation. Variables were compared with Fisher-Freeman-Halton test or Kruskal-Wallis ANOVA test. p < 0.05 was considered statistically significant. CABG, coronary artery bypass graft; CABG bimammaria, CABG using both mammary arteries; AKE, aortic valve replacement; MKE/R, mitral valve reconstruction/replacement; p100, perfusion time 100-200 min; p200, perfusion time 200-300 min; LOS, length of stay in hospital. The postoperative pain was analysed with the visual analog scale. It showed no difference between the vest and non-vest group (Fig. 2) .
The length of hospital stay was significantly longer in patients with complications (Mann-Whitney U test 22 days AE 19.6 SD) compared to patients without complications (11 days AE 10.7 SD). Taking the increased use of antibiotics and vacuum assisted devices in patients with sternum complications in account the cost effectiveness in the vest group is three-fold.
Discussion
The aim of this prospective randomised study was to prove the effect of the thorax support vest to prevent sternal wound complications. Prior to and in consideration of different variables causing sternum infections we changed our process of care. To prevent this complication we use proper antibiotic prophylaxis, attention to sterile technique and antibiotic covered suture material. Thus the rate of infections could be reduced in the past and is comparable with the findings of other study groups [1] [2] [3] [4] [5] , but with 3.6% deep sternum infection it is still not satisfactory. There was no death in the entire cohort caused by infection, which can be accounted to early recognition and aggressive treatment of sternal wound complications.
The association of obesity, diabetes, chronic obstructive pulmonary disease, NYHA score >3, peripheral vascular disease, use of bilateral internal mammary arteries, duration of operation and ventilation with increased risk of sternal wound complications were reported in several studies [2, [6] [7] [8] [9] 13, 14] . The identification of reliable risk factors is important to carefully select patients needing special attention in perioperative and postoperative periods.
We used a risk scoring system created by Fowler et al. [18] to identify patients undergoing cardiac surgery, who are at high risk of major infection. This risk score estimates that probability of infection at nine points is more than 3%. There was no difference between the vest and non-vest group in the identified risk score values, the mean risk score was 8 and 9, which underline that both groups were well matched in this prospective, randomised study.
In our study the prevalence of wound infection after hospital discharge was 25%. In the literature sternal wound infection occurs between 4 and 30 days after cardiac surgery [3, 4, 20] . Other authors support 90 days postoperative surveillance for a reliable assessment of wound infections since up to 48% of sternal wounds infections were diagnosed after hospital discharge, with a median time of 26 days after hospital stay [16, 17] . This long time interval suggests that the late onset of sternal infection is not operation or surgeon related but influenced by postoperative wound management [17, 21] .
The special attention to postoperative wound care leads to the need for an adequate stabilisation of the sternum after sternotomy. A few experimental studies compared the mechanical stability of the sternum using a variety of wiring techniques and other sternotomy closure material [22, 23] . Measurement focusing on increased intrathoracic pressure showed a sternal separation of 2 mm at 46.8 mmHg of pressure. Strong coughing during extubation periods or postoperative course increases the intrathoracic pressure to 300 mgHg [24] . This produces shearing forces in the anterior-posterior and lateral directions.
In conclusion the thorax support vest is designed to avoid tilting of the sternum halves and prevents pressure to the wires. The clinical findings indicate a significant reduction of sternum wound complications. We suppose that the vest supports the mechanical stability after sternotomy and prevents separation and consecutive postoperative dehiscence. Subsequent biomechanical studies are mandatory to evaluate geometrically forces provided by the thorax support vest.
